????他不是唯一一個(gè)懷著這種想法的人。今年，“2045行動(dòng)”將在紐約舉辦第二屆全球未來2045大會(huì)（Global Future 2045 Congress），演講嘉賓包括著名的未來學(xué)家和投資人雷?庫茲韋爾，艾克斯獎(jiǎng)基金會(huì)（X PRIZE Foundation）前主席和企業(yè)家彼得?戴爾蒙迪斯博士，共同創(chuàng)立人類基因組計(jì)劃（Human Genome Project）的分子生物學(xué)家喬治?丘奇博士，以及一大批在商業(yè)、機(jī)器人技術(shù)、神經(jīng)系統(tǒng)科學(xué)和靈學(xué)領(lǐng)域具有影響力的思想領(lǐng)袖。包括庫茲韋爾和戴爾蒙迪斯在內(nèi)的幾位支持者最近在一封寄給聯(lián)合國（UN）秘書長潘基文的信件上簽字，邀請(qǐng)他參加今年6月召開的2045大會(huì)。這次大會(huì)將探討人類和“2045行動(dòng)”的未來。

????伊茨科夫可能會(huì)在這屆大會(huì)上宣布創(chuàng)建自己的永生公司。“2045 行動(dòng)”的永生技術(shù)在21世紀(jì)40年代成熟時(shí)，該公司的投資者可以優(yōu)先享用該技術(shù)?！拔蚁?，如果我們接觸那些對(duì)神經(jīng)系統(tǒng)科學(xué)感興趣的高凈值人士，他們肯定會(huì)抓住延年益壽、同時(shí)把這項(xiàng)技術(shù)帶給人類的機(jī)會(huì)，”伊茨科夫說?！叭绻麄儼堰@項(xiàng)技術(shù)帶給了每個(gè)人，他們?yōu)槭裁床粦?yīng)該優(yōu)先獲得人工軀體呢？”

????玄機(jī)在于：雖然伊茨科夫正在為“2045行動(dòng)”尋找早期投資者，但按照他的想法，這個(gè)公司實(shí)體（以研究中心的身份面世，然后隨著意識(shí)、腦機(jī)接口和永生技術(shù)的發(fā)展而逐漸擴(kuò)大為科技孵化器）將先以非盈利模式運(yùn)行十年，把所有收益都再投資于這項(xiàng)研究，十年后才會(huì)轉(zhuǎn)為盈利模式，開始為投資者創(chuàng)造回報(bào)。

????當(dāng)然，這里的真正回報(bào)不是在未來上市后股價(jià)上漲的機(jī)會(huì)，而是使個(gè)人意識(shí)擺脫肉體、永世長存的機(jī)會(huì)?？梢园阉Q為回報(bào)無限大的長期投資。（財(cái)富中文網(wǎng)）

????譯者：千牛絮

????He's not the only one. Speakers at this year's Global Future 2045 Congress in New York City—the second annual event put on by the 2045 Initiative—include legendary futurist and investor Ray Kurzweil, former X PRIZE Foundation chairman and entrepreneur Dr. Peter H. Diamandis, and Dr. George Church, the molecular biologist who helped initiate the Human Genome Project, as well as a long list of influential thought leaders in business, robotics, neuroscience, and spirituality.. Several of these backers, including Kurzweil and Diamandis, recently signed a letter sent to UN Secretary General Ban Ki-moon inviting him to join the 2045 Congress when it convenes in June to talk about the future of both humanity and the 2045 Initiative.

????It's at this Congress that Itskov will likely announce the launch of his immortality business, which will quite literally allow investors to purchase a place at the front of the line once the initiative's immortality technology matures in the 2040s. "I think if we approach some high net worth individuals with an interest in neuroscience, they would seize the opportunity to both extend their own lives and to bring this technology to humanity," Itskov says. "And if they are responsible for bringing this technology to everybody, why don't they get their artificial bodies first?"

????There is a catch: Though Itskov is looking for initial investors to get in on the ground floor, he envisions this corporate entity—which will enter the world as a research center but expand into a technology incubator as the consciousness/brain-machine-interface/immortality space grows—operating like a non-profit for the first ten years, investing all profits back into the research. After a decade it would shift to a for-profit model and begin paying off for investors.

????Of course, the real payoff here isn't the opportunity to dump shares after some future IPO, but the chance to keep one's consciousness alive indefinitely, long after the biological body has given out. Call it a long-term investment, and one with incalculable ROI.